| Insider | Role | Shares | Value | Buys | Sells |
|---|
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Moore Paul Andrew
Chief Scientific Officer
1 company
Holdings by Company
Current Shares70.0K
Est. Value-
Net Activity-50,870
Bought: 0Sold: 50.9K
Transaction History
Showing 5 transactions
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2026-01-12 | ZYME | Chief Scientific Officer | Sale+OE | 9,560 | $22.67 | $216,758.66 | -16.5% | → |
| 2026-01-05 | ZYME | Chief Scientific Officer | Sale+OE | 20,110 | $25.10 | $504,698.66 | -21.9% | → |
| 2025-01-06 | ZYME | Chief Scientific Officer | Sale+OE | 21,200 | $14.92 | $316,390.92 | -35.8% | → |